Target Name: MYO5C
NCBI ID: G55930
Review Report on MYO5C Target / Biomarker Content of Review Report on MYO5C Target / Biomarker
MYO5C
Other Name(s): Myosin 5C | myosin VC | myosin-Vc | MYO5C_HUMAN | Unconventional myosin-Vc | Myosin VC | MGC74969 | myosin 5C

MYO5C: A Potential Drug Target and Biomarker for Muscle-Related Conditions

Myosin 5C (MYO5C) is a protein that is expressed in muscle tissue and is involved in muscle contraction and relaxation. It is a key player in the myosin system, which is responsible for generating force during muscle contractions.MYO5C has been identified as a potential drug target and has been shown to play a role in a variety of muscle-related conditions, including myopathies, myopathic fibromyalgia, and polymyositis.

The myosin system is a complex network of proteins that work together to generate force during muscle contractions. The myosin heads, which are the protein components of the myosin filament, are responsible for generating the force that leads to muscle contraction. The myosin ATPase, which is located at the base of the myosin filament, is responsible for regulating the amount of ATP that is released to drive the myosin heads down the myosin filament.MYO5C is a protein that is expressed in muscle tissue and is involved in the myosin system.

MYO5C has been shown to play a role in a variety of muscle-related conditions. For example, it has been shown to be involved in the development of myopathies, which are conditions that cause muscle weakness or dysfunction. Additionally, MYO5C has been shown to be involved in myopathic fibromyalgia, a condition that causes muscle pain and stiffness.

MYO5C has also been shown to be involved in the development of polymyositis, a condition that causes progressive muscle weakness and dysfunction. In these conditions, the myosin system is impaired, which can lead to muscle weakness and dysfunction.

In addition to its role in muscle-related conditions, MYO5C has also been shown to be a potential drug target. Studies have shown that inhibiting MYO5C can lead to improvements in muscle strength and function in a variety of muscle-related conditions. Additionally,MYO5C has been shown to be involved in the regulation of muscle growth and development, which can make it an attractive target for drugs that are designed to promote muscle growth and development.

MYO5C is also a potential biomarker for muscle-related conditions. The myosin system is involved in the regulation of muscle growth and development, which can make it an attractive target for biomarkers that are used to diagnose or predict the progression of muscle-related conditions.

Conclusion

In conclusion, MYO5C is a protein that is involved in the myosin system and is expressed in muscle tissue. It has been shown to play a role in a variety of muscle-related conditions, including myopathies, myopathic fibromyalgia, and polymyositis. Additionally,MYO5C has been shown to be a potential drug target and a potential biomarker for muscle-related conditions. Further research is needed to fully understand the role of MYO5C in muscle-related conditions and to develop effective treatments.

Protein Name: Myosin VC

Functions: May be involved in transferrin trafficking. Likely to power actin-based membrane trafficking in many physiologically crucial tissues

The "MYO5C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYO5C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MYO6 | MYO7A | MYO7B | MYO9A | MYO9B | MYOC | MYOCD | MYOD1 | MYOF | MYOG | MYOM1 | MYOM2 | MYOM3 | MYORG | Myosin | Myosin class II | Myosin light-chain phosphatase | MYOSLID | MYOSLID-AS1 | MYOT | MYOZ1 | MYOZ2 | MYOZ3 | MYPN | MYPOP | MYRF | MYRF-AS1 | MYRFL | MYRIP | MYSM1 | MYT1 | MYT1L | MYT1L-AS1 | MYZAP | MZB1 | MZF1 | MZF1-AS1 | MZT1 | MZT2A | MZT2B | N-acetylglucosamine-1-phosphotransferase | N-CoR deacetylase complex | N-Terminal Acetyltransferase A (NatA) Complex | N-Terminal Acetyltransferase C (NatC) Complex | N-Type Calcium Channel | N4BP1 | N4BP2 | N4BP2L1 | N4BP2L2 | N4BP2L2-IT2 | N4BP3 | N6AMT1 | NAA10 | NAA11 | NAA15 | NAA16 | NAA20 | NAA25 | NAA30 | NAA35 | NAA38 | NAA40 | NAA50 | NAA60 | NAA80 | NAAA | NAALAD2 | NAALADL1 | NAALADL2 | NAALADL2-AS3 | NAB1 | NAB2 | NABP1 | NABP2 | NACA | NACA2 | NACA3P | NACA4P | NACAD | NACC1 | NACC2 | NAD(P)H dehydrogenase, quinone | NAD-Dependent Protein Deacetylase | NADH dehydrogenase (Complex I) | NADK | NADK2 | NADPH Oxidase | NADPH Oxidase Complex | NADSYN1 | NAE1 | NAF1 | NAG18 | NAGA | NAGK | NAGLU | NAGPA | NAGPA-AS1 | NAGS | NAIF1 | NAIP